Back to Journals

International Journal of General Medicine

ISSN: 1178-7074

Dr Scott Fraser

Dr Fraser

Professor Scott Fraser is a consultant ophthalmologist at Sunderland Eye Infirmary in the North East of the UK. He is also honorary lecturer at the University of Newcastle Upon Tyne and visiting professor at the University of Sunderland. He is a member of the Royal College of Surgeons of Edinburgh and the Royal College of Ophthalmologists.

He trained as an ophthalmologist initially in Newcastle and then completed his training at Moorfields Eye Hospital. At Moorfields he was also a research fellow initially looking into risk factors for late presentation of glaucoma and later as the Friend of Moorfields funded researcher looking at the genetics of glaucoma. He was awarded his MD in 2000.

His main clinical interest is in glaucoma in which he completed subspeciality training at Moorfields. His research interests also include glaucoma but more widely he is interested in factors that alter compliance with eye medications. He also has an interest in evidence based medicine and is an editor for the Cochrane Eyes and Vision group. He has published over 50 peer reviewed articles and over 100 presentations at scientific meetings. He has written chapters for 7 textbooks and has co-written a manual for eye care.

Dr Daniele Castellani

Dr Castellani

Section: Urology

Dr Daniele Castellani is an attending physician in the Urology Department at the University Hospital Ospedali Riuniti di Ancona, Polytechnic University of Le Marche, Ancona, Italy. He is a member of the European Association of Urology. Dr Castellani received his medical degree from the La Sapienza University in Rome, Italy. He was a medical resident in urology, at the University of L’Aquila, Italy.
Dr Castellani's research interests include benign prostatic hyperplasia, uro-oncology, lasers in urology, and urolithiasis.
Dr Castellani is member of the editorial board of several scientific journals. He has published 90 papers in index journals.

Prof. Dr. Mihajlo Jakovljevic

Prof. Dr. Jakovljevic

Section: Public Health

Professor Mihajlo (Michael) Jakovljevic M.D. Ph.D. MAE published аpprox. 300 papers in indexed, peer reviewed journals (Hirsch Factor 62; Citations Count ͌ 66,800+; Cumulative Impact Factor app. 2000+; i-10 index 165). Being a professional health economist and clinical pharmacology physician, his expertise focuses on Emerging Markets and sustainability of health financing across LMICs countries worldwide. In Editor-in-Chief capacity he leads prestigious Cost Effectiveness and Resource Allocation, BMC journal since 2019 (IF=2.532) and was Founding Specialty Editor-in-Chief of Frontiers in Health Economics, based in Lausanne, Switzerland in 2016-2021 mandate (IF=3.709).
He is Professor and Founding Head of The Global Health, Economics and Policy Department at The University of Kragujevac situated in the historical capital of Serbia. He holds a JSPS funded Visiting Professorship at the Institute of Comparative Economic Studies, Hosei University Tokyo Japan. He is also an Expert affiliate of the CHTF IHME University of Washington since 2016 and used to hold a FORTE-funded Visiting Research Fellow position at Lund University, Sweden in the Division of Health Economics in 2018.
For his achievements and professional standing, in 2015 he became the first-ever nominated candidate from Eastern Europe for IHEA (International Health Economics Association) Board of Directors Elections. Over the past twenty years he has delivered plenary lectures and solicited speeches in well over thirty countries across Eurasia. During the past decade he continues to serve as Scientific Committee Member in top tier health economics and demography events such as IHEA, EuHEA, World Sustainability Forum. Since 2018 he continues as a WHO EACHR Committee member in an advisory capacity to the Cabinet of WHO Regional Director for Europe, based in Copenhagen, Denmark. In November 2021 he became first-ever Elected Ordinary Academician coming from Serbia, at the UNESCO World Academy of Sciences TWAS with its headquarters in Trieste, Italy. In June 2022 he was elected to Full Membership within Academia Europea, London, UK.

Dr Woon-Man Kung

Dr Kung

Section: General Medicine

Woon-Man Kung received his M.D. degree from the School of Medicine, Taipei Medical University (TMU), Taipei, Taiwan in 1999. In 2012, he received his M.Sc. degree in Biomedical Engineering from the College of Medicine and College of Engineering, National Taiwan University (NTU), Taipei, Taiwan. Dr. Kung now serves as a Consultant Neurosurgeon in the Division of Neurosurgery, Department of Surgery, Taipei Tzu Chi Hospital (TCH), Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan, as well as an Adjunct Associate Professor in the Department of Exercise and Health Promotion, College of Kinesiology and Health, Chinese Culture University (CCU), Taipei, Taiwan. He further participates as an International Membership of the professional association at the Congress of Neurological Surgeons (CNS), USA. He currently works in the Editorial/Advisory Board of several indexed journals and involves acting as an ad-hoc reviewer for a number of prestigious scientific journals.

Professor Hyam Leffert

Professor Leffert

Section: Hepatology

Professor Leffert attended the University of Rochester, Rochester, NY (B.A., Intellectual History, 1965), where he studied Necturus blood cells with Professor Ernst Caspari; Brandeis University, Waltham, Mass (M.A., Biology, 1967), where he reconstituted a primary immune response in vitro with Professor Gordon Sato; and the Albert Einstein College of Medicine, Bronx, NY (M.D.,1971), where he discovered a lecithinase-producing Bacillus cereus in a newborn suffering from Meningitis and bacteremia after ventriculoatrial shunt-revision (he identified the organism by its GC-base composition with Professor Julius Marmur). His internship at UCSD (La Jolla, CA, 1972) was split between Pediatrics, and Biology, where he developed selection methods to culture proliferation- and differentiation-competent primary hepatocytes for use as model systems of liver development and regeneration.

Dr. Leffert continued basic research at the Salk Institute, where, as an NCI/NIH/Damon Runyon Cancer Research Fellow and an Assistant Professor of Cell Biology, he directed liver growth control studies alongside many students, postdocs, and sabbatical visitors through 1980. Several growth factors were discovered (insulin, glucagon and epidermal growth factor; thereafter, insulin-like growth-factors IGF-I and IGF-II and TGF-α). Later studies provided molecular understanding of relationships between growth factors, regeneration and the expression and biochemistry of cyclins D1, B, A and E. Drs. Koch and Leffert, and Stewart Sell, UCSD Professor of Pathology, also observed expression of α-fetoprotein, a clinical marker of human hepatocellular carcinoma, in neonatal hepatocytes undergoing liver development in vitro and in vivo, and in normal long-term primary hepatocyte cultures simulating liver regeneration. Further work revealed that primary hepatocytes enzymatically converted chemical procarcinogens like N-Acetyl-2-Aminofluorene (AAF) into carcinogenic metabolites -- research that enabled precision drug metabolism studies by the pharmaceutical industry. In 1987, with Professor Ted Friedmann (UCSD Pediatrics), Dr. Leffert introduced genes into hepatocytes using retroviral vectors (initiating hepatic gene therapy research). Dr. Leffert was awarded a John Simon Guggenheim Memorial Fellowship, and a Morton Grossman Research Scholar Award by the American Gastroenterological Association, to study Molecular Cancer Genetics with Sir Henry Harris at the Sir William Dunn School of Pathology at Oxford University.

Currently, Drs. Leffert, Koch and Sell, are focused upon determination of pharmacokinetic growth cycle-dependent metabolic and covalent binding parameters of AAF, and the implication these new findings have with respect to translesion hepatocyte DNA synthesis and the chemical induction of hepatocellular carcinoma.

Prof. Dr. Héctor M Mora-Montes

Prof. Dr. Mora-Montes

During his post as a clinical analyst, Prof. Mora-Montes developed a system for the differentiation of Candida species, based on in-house zymograms and colony morphology in cornmeal agar. As a postgraduate student, he generated a new and innovative method for in situ determination of glycosyl hydrolase activities and received the “Summa Cum Laude” distinction from Universidad de Guanajuato. Among the most important achievements during his time as a postdoctoral fellow at the University of Aberdeen (Scotland), he set up most of the immunological techniques within the Aberdeen Fungal Group and developed and standardized protocols for the isolation and purification of chitin, phospholipomannan, N-linked and O-linked mannans from fungal cells. Those protocols have not only benefited the Aberdeen Fungal Group, but other international groups dedicated to the study of the fungal cell wall, and are considered among the most popular and standardized methods for isolation and analysis of fungal cell wall components. In 2010, he established the Laboratory of Fungal Glycobiology at Universidad de Guanajuato (Mexico), with the main goal to understand the mechanisms behind the fungal cell wall synthesis and the interaction of medically relevant fungal pathogens with the host. This laboratory is characterized by its facilities to perform chemical, immunological, genetic, molecular and cellular analyses of human fungal pathogens. Therefore, it is among a handful of research facilities within Mexico and Latin America offering a multidisciplinary and integral approach to understand these pathogens. Currently, the group is developing molecular tools for genetic manipulation of medically relevant fungi, in particular Sporothrix and Candida species. Our group has a solid international reputation in the genetic study of these organisms, in the immune sensing of fungal cells, and the development of alternative models to analyze fungal virulence. Since 2016, he was awarded the level III distinction by SNI, the highest distinction awarded by the Mexican Government for Mexican Researchers under 65 years old. He currently holds editorial appointments in several peer-reviewed international journals and is the Deputy President of the Latin-American Society of Glycobiology.

Professor Satish Chandrasekhar Nair

Professor Nair

Section: Public Health

Professor Satish Chandra has the unique distinction of serving at senior positions in the pharmaceutical industry and, at academic medical centers in the USA, India and the United Arab Emirates, for over 25 years. He obtained his PhD (faculty of medicine) following graduation from the TN Medical College. In addition, he is American Board certified in medical quality, and informatics. He further obtained MBA in healthcare management from the University of Nebraska. He has proven expertise in clinical trials, designing clinical trails, research ethics, medical ethics, joint commission hospital accreditation, patient safety, medical quality and public health. He has over 100 international peer reviewed PubMed indexed publications. His publications include Lancet, Breast Cancer, International Journal Public health and other reputed publications. He serves on the editorial board of several international journals, and was awarded several global awards such as the Technology Pioneer, Marcus Evans best speaker, and innovative professional awards from the USA, Switzerland, Japan and the UAE. He has authored several COVID-19 publications recently. He is currently the associate professor, college of medicine, UAE University, and the Director for clinical research at Tawam Hospital, Al Ain, UAE. He is involved in medical residency research training.

Prof. Dr. Leonardo O Reis

Prof. Dr. Reis

Section: Urology

Leonardo Oliveira Reis is Professor of Urology and Uro-Oncology at the State University of Campinas, Unicamp and the Pontifical Catholic University of Campinas, PUC-Campinas, Fulbright Visiting Professor at Harvard University, Urology Fellow at Columbia University, New York, NY, USA (American Urological Association, 2011). Postdoctoral Fellow at The Johns Hopkins University, School of Medicine, Baltimore, MD, USA (CAPES, 2014-2015). Research Productivity 1 of the Brazilian National Council for Scientific and Technological Development, CNPq, aimed at researchers who stand out among their peers according to normative criteria. Has experience in Urology, with emphasis on Urological Oncology. He is the author/co-author of >200 scientific articles indexed by PUBMED, >40 Chapters of National and International Books, Top Reviewer @Publons, CAPES Theses Award 2012 Medicina III (Surgery). National and International Ad hoc advisor. Executive Member of the World Urologic Oncology Federation (WUOF). AUA International Member and Scholar. Handling Editor for the World Journal of Urology (Springer), ex-official journal of the Société Internationale d'Urologie (SIU), and Associate and Section Editor, International Brazilian Journal of Urology (IBJU), the official journal of the Brazilian Society of Urology (SBU), and the American Confederation of Urology (CAU). Scientific Director (2018-19) of the Brazilian Society of Urology (SBU), São Paulo Section. President of the Human Ethics Committee for Research (2016-2019) of the Pontifical Catholic University of Campinas, PUC-Campinas. Latin America Top Scientist (AD Scientific Index 2021, 2022). 

Professor Alfonso J Rodríguez-Morales

Professor Rodríguez-Morales

Section: Infectious Diseases

Dr. Rodriguez-Morales is an expert in tropical and emerging diseases, particularly in zoonotic and vector-borne diseases (especially arboviral diseases), now including COVID-19 and Monkeypox. He is President of the Publications and Research Committee of the Pan-American Infectious Diseases Association (API), as well as President of the Colombian Association of Infectious Diseases (ACIN). He is a member of the Committee on Tropical Medicine, Zoonoses, and Travel Medicine of ACIN. He is Vice President of the Latin American Society for Travel Medicine (SLAMVI) and Member of the Council of the International Society for Infectious Diseases (ISID). Since 2014, he has been recognized as Senior Researcher, Ministry of Science of Colombia. He is Professor of the Faculty of Medicine of the Fundacion Universitaria Autonoma de las Américas, in Pereira, Risaralda, Colombia. He is External Professor, Master in Research on Tropical Medicine and International Health, Universitat de Barcelona, Spain. He is also Professor of the Master in Clinical Epidemiology and Biostatistics, Universidad Científica del Sur, Lima, Peru. He was awarded in 2021 with the "Raul Isturiz Award" Medal of the API. Also, in 2021, awarded with the "Jose Felix Patiño" Asclepius Staff Medal of the Colombian Medical College, due to his scientific contributions on COVID-19 during the pandemic. He is currently the Editor in Chief of the journal Travel Medicine and Infectious Diseases. His Scopus H index is 51 (Google Scholar H index, 72).

Dr Hossam El-Din Shaaban

Dr Shaaban

Section: Gastroenterology

Dr. Hossam is currently a gastroenterology and endoscopy consultant at North Cumbria Integrated Care NHS Foundation Trust. He was graduated from Cairo University Faculty of Medicine in 2001. He got his Masters Degree in Internal Medicine in 2009, then his Medical Doctorate in Internal Medicine in 2018 both from Cairo University. He is a fellow the American College of Gastroenterology (ACG) and the American Society of Gastrointestinal Endoscopy (ASGE). Dr. Hossam authored 40 peer reviewed journal publications. He serves as a peer reviewer for multiple journals. His current H-index is 7 in Google Scholar, and 6 in Scopus and Clarivate Web of Science. 

Prof. Dr. Yuriy Sirenko

Prof. Dr. Sirenko

Section: Cardiology

Professor Yuriy Sirenko is Head of Department of Arterial Hypertensions in the National Scientific Center "M.D. Strazhesko Institute of Cardiology, Clinical and Regenerative Medicine" of the National Academy of Medical Science. His research interests include primary and secondary arterial hypertension, cardio-vascular prevention, pulmonary arterial hypertension, heart failure, right heart catheterization, hemodynamic changes, role of RAS, coronary artery disease, drug and non-drug therapy, emergency and intensive care in cardiology, and coronary artery disease. He has completed more than 600 publications in the fields of cardiology and hypertension.

Professor Luca Testarelli

Professor Testarelli

Section: General Medicine

Dr. Luca Testarelli is an associate professor of Dental Restorative and Endodontics at Sapienza University of Rome, and Oral Care in School of Dental Hygienist in Sapienza University of Rome since 2006. His career began in 2000 with the degree cum laude as Doctor of Dental Sciences at Sapienza University of Rome and followed by a PhD degree (2004) and specialization in Orthognathodontics (2008). Since 2011 he has practiced as a dentist in the Dental Clinic of Policlinico Umberto I’s Hospital of Rome.
He is member of several scientific national and international associations and member of editorial boards of several dental scientific journals. His research interests and activity are mostly related to dentistry and specifically focused on lines of research, such as: cross-infection control in Dentistry, experimental in vitro and in vivo evaluation of dental materials used in endodontic practice, particularly related to nickel-titanium rotary instruments, sealers and irrigants, experimental in vitro and in vivo evaluation of dental materials for dental hygienists, implantology and 3D dental radiology.


Dr Dinesh Vyas

Dr Vyas

Section: Oncology

Dr. Vyas is a distinguished internationally acclaimed surgeon, and researcher, academic leader, business executive, mass media exploit educator, global health pioneer in prehospital care pedagogy, and a trailblazer in the space of medical device innovation.
With an extensive experience and successful career as Associate Dean of Surgery Research, CEO, CMO, Chair of University and Community Surgery Department, Program Director Surgery Residency, and Innovation, Research & Quality Head, Dr. Vyas has mentored many academic physicians. He is among the top ten advanced robotic gastrointestinal surgeons in Northern California, performing a high volume of cases with exceptional outcomes.
An advisor to multiple funds & startups, while promoting innovation thru his incubator with four startups. In addition, pioneer of MOOC in the medical space. Dr. Vyas is an avid learner and surrounds himself with more knowledgeable people, and exemplifies the fortitude of thriving in uncharted terrains. His scientific work is known for several medical firsts and published in the prestigious journals like iScience. First Surgeon of Southeast Asian training to have a contributed as both Surgery Program Director, and University Surgery Department Chair, enriching the US education system. NPR, Gulf Times published his work and keynote speaker at FT healthcare and Beckers CEO and other prestigious conferences.
Dr. Vyas has made surgical, basic science (nanotechnology) and clinical contributions and improved care like substantially decreasing complications of gangrenous gallbladder surgery (35% to 5%); esophageal perforation, a largest series on underwater colonoscopy for increasing trained endoscopists; the largest robotic surgery series on gastric volvulus with hiatal hernia, and more.
Dr. Vyas’ eclectic list of major accomplishments includes over 100 peer reviewed publications (h-index 21) and abstracts, 200 invited talks, editor-in-chief of two textbooks, editor-in-chief of three journals, founder of multiple trauma training centers, and more than fifteen patents published or in the process.
Dr. Vyas’ incubator has several success stories, and he has a few medical devices ready for prime time. StaplCam is the world's first fully disposable operating room system nearly ready for FDA clearance. SMORTS, a disruption in injury prediction using AI/ML in a smart garment enhancing warehouse industry and sports personnel.
Dr. Vyas’ philosophy is: "Efforts must be designed to have an impact."
Training: University of Pittsburgh, Case Western Reserve University, and Rajasthan University.

Dr Sandul Yasobant

Dr Yasobant

Section: Public Health

Sandul Yasobant is working as a Technical Officer (Research) at the Indian Institute of Public Health Gandhinagar (IIPHG), India; a Postdoc fellow at the Institute for Hygiene & Public Health, University Hospital Bonn, Germany; an Associate Researcher at the Center for Development Research (ZEF), University of Bonn, Germany; an Adjunct Faculty at the Datta Meghe Institute of Medical Sciences (DMIMS), India. He also holds editorial affiliations with Springer Nature, Frontiers, PLOS, and Taylor & Francis. Originally from Odisha (eastern India), Yasobant has completed his health education and public health training at Utkal University, Sri Ramachandra University in India, and the University of Bonn in Germany. He has completed the Doctoral Program ‘One Health & UrbanTransformation’ at ZEF and obtained a public health doctoral degree from the medical faculty, University of Bonn, Germany, in 2020. Yasobant’s research incorporates health policy and system research, One Health and disease prevention, and environment and occupational health. Yasobant has conducted extensive research in Southeast Asia and is currently engaged in research activities in India and Ghana. He has published more than 50 peer-reviewed international journal articles and three book chapters and edited one volume of a book.

Editorial Board

Priyanka Bhugra, MD, Assistant Professor of Clinical Medicine, Department of Medicine, Houston Methodist Hospital, and Assistant Professor Weill Cornell Medical College Houston, USA.

Charlie Bridgewood, PhD, Leeds Institute of Rheumatic & Musculoskeletal Medicine, University of Leeds, United Kingdom.

Kevin W. Chamberlin, PharmD, FASCP, Associate Clinical Professor of Pharmacy Practice, UConn School of Pharmacy; Adjunct Associate Clinical Professor, Department of Medicine, UConn Health, CT, USA


Gopal Krishna Dhali, Professor and Head, Division of Gastroenterology, School of Digestive & Liver Diseases, Institute of Post Graduate Medical Education & Research, S.S.K.M Hospital, India. 

Perenlei Enkhbaatar, Professor, Department of Anesthesiology, Director of Translational Intensive Care Unit, Charles Robert Allen Professor in Anesthesiology; University of Texas Medical Branch, Galveston TX, USA

Asghar Fazaeli, Department of Medical Parasitology and Mycology, Medical School, Zanjan University of Medical Sciences, Iran

Levent Filik, Professor of Gastroenterology, Gastroenterology Unit, Ankara Research Hospital, Turkey

Domenico Giannese, Nephrology Department of the Pisa University Hospital, Italy. 

Dr Anju Gupta, Assistant Professor, Department of Anesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciences, New Delhi, India

Anut Itthagarun, Professor, Department of Pediatric Dentistry, School of Dentistry and Oral Health, Griffith University, QLD, Australia

Robert Kaplan, Clinical Excellence Research Center (CERC), Stanford University, Stanford, CA, USA

Shinichi Mitsui, Professor, Department of Rehabilitation Sciences, Gunma University Graduate School of Health Sciences, Gunma, Japan

Franz Oesch, Emeritus Professor and Emeritus Director, Institute of Toxicology, University of Mainz, Germany

Russell S. Phillips, M.D., William Applebaum Professor of Medicine and Director, Center for Primary Care, Harvard Medical School, Harvard University, Boston, MA, USA.

Amit Ray, Neurologist, Director Neurology, Aurora Healthcare, Kenosha, WI, USA

Kamal Kant Sahu, M.D, Hematology & Medical Oncology Fellow, Huntsman Cancer Institute, University of Utah, USA. 

Taro Shimizu, MD, PhD, MPH, MBA, Professor, Department of Diagnostic and Generalist Medicine, Dokkyo Medical University Graduate School of Medicine, Chair, Department of Diagnostic and Generalist Medicine, Dokkyo Medical University Hospital, Tochigi, Japan.

Vasileios Zochios, University Hospitals Birmingham NHS Foundation Trust; Department of Critical Care Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing; Centre of Translational Inflammation Research, University of Birmingham, Birmingham, UK